Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
3.335 USD | +0.15% |
|
-5.93% | -20.90% |
06-24 | CureVac N.V. Approves the Appointment of Birgit Hofmann as a Member of the Supervisory Board | CI |
05-28 | CureVac, GSK Begin Dosing in Phase 2 Study for Seasonal Influenza Vaccine Candidate | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-20.90% | 747M | |
+17.68% | 44.44B | |
-10.29% | 37.99B | |
+37.55% | 37.75B | |
+29.32% | 30.78B | |
-8.44% | 27.38B | |
+12.27% | 26.17B | |
+44.20% | 14.15B | |
+31.78% | 12.59B | |
-7.67% | 11.28B |
- Stock Market
- Equities
- CVAC Stock
- News CureVac N.V.
- CUREVAC : Berenberg reaffirms its Buy rating